0001855763-23-000003.txt : 20230725 0001855763-23-000003.hdr.sgml : 20230725 20230725135604 ACCESSION NUMBER: 0001855763-23-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230725 FILED AS OF DATE: 20230725 DATE AS OF CHANGE: 20230725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REESE ALBERT L JR CENTRAL INDEX KEY: 0001244736 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39874 FILM NUMBER: 231107942 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 BUSINESS ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 BUSINESS PHONE: 250-765-6424 MAIL ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2023-07-25 0 0001348362 Lexaria Bioscience Corp. LEXX 0001244736 REESE ALBERT L JR 23 NORTH SEASONS TRACE THE WOODLANDS TX 77382 1 0 0 0 0 common shares 10917 D Stock Options 3 2021-02-01 2026-02-01 Common Shares 3400 3400 D Stock Options 3.39 2022-03-08 2027-03-08 Common Shares 3400 6800 D Stock Options 1.96 2022-10-12 2027-10-12 Common Shares 3200 10000 D Stock Options 0.87 2023-07-25 4 A 0 5000 0 A 2023-07-25 2028-07-25 Common Shares 5000 15000 D Repriced from $4.80 pursuant to shareholder approval received on May 9, 2023. /Albert Reese Jr./ 2023-07-25